A multimodal sleep foundation model based on polysomnography data can predict the risk for multiple conditions.
AliveCor, the global leader in AI-powered cardiology, today announced it has received U.S. Food and Drug Administration (FDA) ...
AliveCor announced today that it received FDA clearance for the next generation of its AI technology for the Kardia 12L ECG ...
Long-term MACE and mortality rates are comparable between patients with and without diabetes following IVL-assisted percutaneous coronary intervention.
Money Talks News on MSN
The 5 deadliest heart conditions in America today — and their biggest risk factors
A new report reveals that progress against heart disease has stalled while key risk factors continue to climb.
Spurred by her grandfather’s MI to pursue a career in medicine, this fellow finds inspiration in outcomes research.
Verywell Health on MSN
Turmeric vs. Magnesium: Which Is Better for Inflammation?
Both turmeric and magnesium can offer health benefits, but which is better for inflammation, heart health, and relaxation?
The Chosun Ilbo on MSN
Scientists challenge microplastics-in-brain claims, cite method flaws
Recent studies have successively reported the discovery of microplastics and nanoplastics throughout our bodies. This ...
New studies raise the possibility that GLP-1 medications beat aspirin in reducing colorectal cancer risk, and may improve ...
Nottinghamshire Live on MSN
Full list of medical conditions you must declare to DVLA
Drivers could face up to £1,000 fines and potential prosecution if they fail to report notifiable medical conditions or ...
In a significant development for diabetes care in Canada, Novo Nordisk has announced that Health Canada has approved RYBELSUS® (semaglutide tablets) for reducing cardiovascular risks in adults with ...
Virtual simulation platforms often fail to meaningfully reflect patient diversity, which may be shaped by underlying biases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results